Starling Oncology, Inc. (STLNW) fundamentals score
TOI treats patients across 17 markets and five states throughout the United States, via its 65 clinics owned by affiliated physicians and staffed with 116 providers (the "TOI PCs"), 81 independently-owned clinics which are contracted with TOI's managed services organization, as well as its contracted network of 198 independent providers unaffiliated with TOI in instances where TOI is the fully delegated market manager under a value-based contract.
Services-Offices & Clinics of Doctors of Medicine · Healthcare · Listed on NASDAQ
Overall: 5.0 out of 10, Mixed fundamentals
- Growth: 5.4/10
- Profitability: 3.9/10
- Financial health: 2.8/10
- Earnings quality: 8.3/10
- Valuation: 5.5/10
Scores are calculated from Starling Oncology, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10